Related Experiment Video
Updated: Jun 11, 2025

12:18
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
7.5K
Automatic selection model to identify neurodegenerative diseases.
Eddy Sánchez-DelaCruz1, Cecilia-Irene Loeza-Mejía1, César Primero-Huerta1,2
1Artificial Intelligence Laboratory, Tecnológico Nacional de México/Instituto Tecnológico Superior de Misantla, Veracruz, Mexico.
Digital Health
|October 7, 2024
Summary
Machine learning accurately classifies Parkinson's disease and Huntington's disease using non-invasive gait biomarker data. This approach shows promise for advancing neurological disorder diagnostics.
Area of Science:
- Neurology
- Biomedical Engineering
- Data Science
Background:
- Parkinson's disease and Huntington's disease are debilitating neurological disorders.
- Accurate and early diagnosis is crucial for effective management.
- Non-invasive diagnostic methods are highly desirable to reduce patient burden.
Purpose of the Study:
- To evaluate the effectiveness of machine learning algorithms in classifying Parkinson's disease and Huntington's disease.
- To utilize non-invasive biomarker data for disease classification.
- To explore the potential of a unique Mexican human gait biomarker database.
Main Methods:
- Collected accelerometer biomarker data (x, y, z values) from Parkinson's disease patients, Huntington's disease patients, and healthy controls.
- Implemented an automatic selection model for disease classification.
- Employed Random Forest, Random Subspace Method, and K-star algorithms with automated parameter optimization.
Main Results:
- Achieved a 0.893 precision rate for classifying Parkinson's disease and Huntington's disease using the Random Subspace Method.
- Demonstrated the efficacy of the automatic selection model method.
- Highlighted the potential of machine learning in medical diagnosis.
Conclusions:
- Machine learning algorithms, particularly the Random Subspace Method, show significant potential for classifying neurological disorders.
- Non-invasive biomarker data can be effectively utilized for disease diagnosis.
- This research contributes to advancing non-invasive diagnostic approaches in neurology and underscores the role of AI in healthcare.

